Abbonarsi

Prevalence and predictors associated with severe pulmonary hypertension in COPD - 28/02/18

Doi : 10.1016/j.ajem.2017.08.014 
Mitra Samareh Fekri, MD a, Mehdi Torabi, MD b, , Sara Azizi Shoul, MD c, Moghaddameh Mirzaee d
a Associate Professor of Pulmonology Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran 
b Assistant Professor of Emergency Medicine, Department of Emergency Medicine, Kerman University of Medical Sciences, Clinical Research Center, Afzalipour Hospital, Kerman, Iran 
c Department of Emergency Medicine, Kerman University of Medical Sciences, Kerman, Iran 
d Department of Biostatistics and Epidemiology, School of Public Health, University of Medical Sciences, Kerman, Iran 

Corresponding author.

Abstract

Background

Pulmonary hypertension (PH) is one of the most common complications of COPD (chronic obstructive pulmonary disease), but its severe form is uncommon. Various factors play an important role in the occurrence and severity of pulmonary hypertension in patients.

Methods

This cross-sectional study was performed on patients with COPD referred to an emergency department over a one-year period. The tests—including complete blood count (CBC) and arterial blood gas (ABG), pulmonary functional test (PFT) and echocardiography—were performed for all patients to measure mPAP (mean pulmonary artery pressure), ejection fraction (EF) and body mass index (BMI). The prevalence of severe pulmonary hypertension and its associated factors were investigated in these patients.

Results

A total of 1078 patients was included in the study, of whom 628 (58.3%) were male and 450 (41.7%) were female. The mean age of the patients undergoing the study was 70.1±12.2. A total of 136 (13.7%) of them had mPAP (mm Hg)40mm Hg as severe pulmonary hypertension. Following multivariable analysis by using the backward conditional method, it was shown that seven variables had a significant correlation with severe PH.

Conclusions

The results showed that there is an independent correlation between hypoxia, hypopnea and compensatory metabolic alkalosis, polycythemia, left ventricular dysfunction, emaciation, and cachectic with severe pulmonary hypertension. The prevalence of severe PH in these patients was 13.7%.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : BMI, COPD, EF, FEV1, FVC, mPAP, MPV, PDW, PFT, PH, RDW

Keywords : Pulmonary hypertension, COPD, Body mass index, Cachexia


Mappa


© 2017  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 36 - N° 2

P. 277-280 - febbraio 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Incidence and risk factors of delayed intracranial hemorrhage in the emergency department
  • Byunghyun Kim, Hyeonjeong Jeong, Joonghee Kim, Tackeun Kim, Kyuseok Kim, Heeyoung Lee, Soyeon Ahn, Yoo Hwan Jo, Jae Hyuk Lee, Ji Eun Hwang
| Articolo seguente Articolo seguente
  • High rate of isolated right ventricular dysfunction in patients with non-significant CT pulmonary angiography
  • Frances M. Russell, Jeffrey A. Kline, Timothy Lahm

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.